The Institute

The Institute for Pharmacology and Toxicology (IPT) is located in the Biomedical Centre 1. The building was built in 2009 and assembles various institutes of the field of life science at the university and the university hospital Bonn. 

Since 2006, the Institute for Pharmacology and Toxicology has been headed by Prof. Dr. Alexander Pfeifer.

Our research groups

At our institute one can find three research groups. While the topic of "metabolism" serves as a common focus, each research group focuses on a specific aspect of this broad subject area.

Pfeifer group

Alexander Pfeifer has a long-standing interest in cellular signaling, molecular pharmacology and academic drug research. He has been doing pioneering work in the field of purinergic signaling and the NO/cGMP pathway as well as contributed to the field of G-protein coupled receptors. For several years, he studies these pharmacologically important signaling pathways to identify drug targets and to develop novel therapeutic approaches. A major focus of his research lies on metabolic diseases and energy homeostasis. He is speaker of the DFG-funded Collaborative Research Center CRC/TRR333 “BATenergy”.

Another important topic of his research is gene and drug delivery, where he is focusing on lentiviral vectors and nanoparticles to deliver genetic material and drug molecules respectively, to target specific cells and tissues. He was also the speaker of the DFG Research Unit FOR917 and the DAAD Strategic Network Europe-Japan on multimodal nanoparticles.

© Saba/UKB

von Kügelgen group

Ivar von Kügelgen focuses on purinergic transmission and the molecular pharmacology of P2Y receptors and related orphan receptors. He is highly interested in the clarification of the physiological as well as pathophysiological roles of these receptors and their molecular pharmacological properties.

© von Kügelgen

Li group

Yongguo Li has strong expertise in pharmacologically targeting GPCRs and GPCR signaling, especially Gs-coupled cAMP signaling, in metabolic diseases such as obesity and diabetes. His group employs a combination of state-of-the-art molecular technologies, organoids, and pharmacological screening to study the role of GPCR/cAMP signaling on fat metabolism to reveal druggable GPCRs and potential drugs that target them. The central research goal is to unravel potential therapeutically targetable mechanisms and promising drugs, which have fundamental implications for achieving metabolic health and combating metabolic diseases such as obesity, diabetes, and cardiovascular diseases.”

P12 Li.png.jpg
© Li

The biomedical centre

The building consists of three parts: the four-story lab section, the four-story office section and two lecture halls. They are all connected via a shared hall. 

© Uni Bonn
Eine Wissenschaftlerin und ein Wissenschaftler arbeiten hinter einer Glasfassade und mischen Chemikalien mit Großgeräten.
© Uniklinikum Bonn

Access to the office and lab section is enabled via ladders and bridges, which connect the lab wing with the office wing. 

There is also a small bistro located in the BMC 1.

The IPT is situated in the second floor. The lac section is distributed over several stories, among them S2 labs.

Des Weiteren befindet sich im BMZ 1 auch ein Bistro.

Approach and site map

Location of the biomedical centre on the Venusberg, Bonn:

Building 13, Venusberg-Campus 1, 53127 Bonn (across the emergency room)


Prof. Dr. Alexander Pfeifer

Venusberg Campus 1

53127 Bonn

Melek Yildiz

Venusberg Campus 1

53127 Bonn

Andrea Vamos

Venusberg Campus 1

53127 Bonn

Wird geladen